These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21413853)

  • 1. Well-differentiated pancreatic islet cell carcinoma: Is there reversibility in mTOR inhibitor resistance?
    Walter T; Scoazec JY; Couderc C; Forestier J; Roche C; Chayvialle JA; Lombard-Bohas C
    Acta Oncol; 2011 Jun; 50(5):731-2. PubMed ID: 21413853
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.
    Kouvaraki MA; Ajani JA; Hoff P; Wolff R; Evans DB; Lozano R; Yao JC
    J Clin Oncol; 2004 Dec; 22(23):4762-71. PubMed ID: 15570077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhinitis in patients treated with a combination of an mTOR inhibitor and an EGFR inhibitor.
    Prulière-Escabasse V; Gomez-Roca C; Escudier E; Coste A; Besse B; Massard C; Soria JC
    Onkologie; 2010; 33(7):401-2. PubMed ID: 20631489
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma.
    de Vries H; Mulder NH; de Vries EG
    Cancer; 2000 May; 88(9):2194-5. PubMed ID: 10813734
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting endocrine resistance: is there a role for mTOR inhibition?
    Sheri A; Martin LA; Johnston S
    Clin Breast Cancer; 2010 Nov; 10 Suppl 3():S79-85. PubMed ID: 21115426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pancreatic islet cell carcinoma with multiple hepatic metastases successfully treated with a streptozocin/5-FU regimen--a case report].
    Arakawa Y; Mizunuma N; Aiba K; Ito Y; Takahashi S; Irie T; Watanabe J; Tada K; Okudaira T; Seki M; Yamaguchi T; Muto T; Hatake K
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2561-4. PubMed ID: 12506483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [mTOR inhibitor].
    Muro K
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):7-11. PubMed ID: 21368454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor.
    Bettini R; Partelli S; Boninsegna L; Capelli P; Crippa S; Pederzoli P; Scarpa A; Falconi M
    Surgery; 2011 Jul; 150(1):75-82. PubMed ID: 21683859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma.
    Ekshyyan O; Mills GM; Lian T; Amirghahari N; Rong X; Lowery-Nordberg M; Abreo F; Veillon DM; Caldito G; Speicher L; Glass J; Nathan CO
    Head Neck; 2010 Dec; 32(12):1619-28. PubMed ID: 20222045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma.
    Schedel F; Pries R; Thode B; Wollmann B; Wulff S; Jocham D; Wollenberg B; Kausch I
    Oncol Rep; 2011 Mar; 25(3):763-8. PubMed ID: 21240463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric and ATP-competitive kinase inhibitors of mTOR for cancer treatment.
    García-Echeverría C
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4308-12. PubMed ID: 20561789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.
    Butturini G; Bettini R; Missiaglia E; Mantovani W; Dalai I; Capelli P; Ferdeghini M; Pederzoli P; Scarpa A; Falconi M
    Endocr Relat Cancer; 2006 Dec; 13(4):1213-21. PubMed ID: 17158766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temsirolimus for metastatic desmoplastic small round cell tumor.
    Thijs AM; van der Graaf WT; van Herpen CM
    Pediatr Blood Cancer; 2010 Dec; 55(7):1431-2. PubMed ID: 20730888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An effective case of hepatic arterial infusion chemotherapy based on biochemical modulation for hepatic recurrence of non-functioning islet cell carcinoma of the pancreas].
    Nishijima K; Ohta T; Elnemr A; Yi S; Ninomiya I; Kitagawa H; Fushida S; Nishimura G; Fujimura T; Kayahara M; Shimizu K; Miwa K
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1926-30. PubMed ID: 11086447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet cell carcinoma treated by induction regional chemotherapy and radical total pancreatectomy with liver revascularization and small bowel autotransplantation.
    Lai DT; Chu KM; Thompson JF; Gallagher JP; Waugh R; Storey DW; Stephen MS
    Surgery; 1996 Jan; 119(1):112-4. PubMed ID: 8560375
    [No Abstract]   [Full Text] [Related]  

  • 16. Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma.
    Cheng PN; Saltz LB
    Cancer; 1999 Sep; 86(6):944-8. PubMed ID: 10491519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell cancer: the unmet needs.
    Durán I
    Anticancer Drugs; 2011 Jan; 22 Suppl 1():S1-3. PubMed ID: 21173602
    [No Abstract]   [Full Text] [Related]  

  • 18. The dual PI3K/mTOR inhibitor BEZ235 is effective in lung cancer cell lines.
    Herrera VA; Zeindl-Eberhart E; Jung A; Huber RM; Bergner A
    Anticancer Res; 2011 Mar; 31(3):849-54. PubMed ID: 21498705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Locoregional and systemic therapy of advanced pancreatic carcinoma].
    Gebauer T; Ridwelski K; Fahlke J; Lippert H
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1344-7. PubMed ID: 9931877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-methylpteridinones as orally active and selective PI3K/mTOR dual inhibitors.
    Liu KK; Bagrodia S; Bailey S; Cheng H; Chen H; Gao L; Greasley S; Hoffman JE; Hu Q; Johnson TO; Knighton D; Liu Z; Marx MA; Nambu MD; Ninkovic S; Pascual B; Rafidi K; Rodgers CM; Smith GL; Sun S; Wang H; Yang A; Yuan J; Zou A
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6096-9. PubMed ID: 20817449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.